Charles Bennett to Sarcoma, Kaposi
This is a "connection" page, showing publications Charles Bennett has written about Sarcoma, Kaposi.
Connection Strength
0.361
-
Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma. Acta Oncol. 1999; 38(8):1063-7.
Score: 0.154
-
Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):460-5.
Score: 0.150
-
Pharmacoeconomics of liposomal anthracycline therapy. Semin Oncol. 2004 Dec; 31(6 Suppl 13):191-5.
Score: 0.058